Global /India /Healthcare /Drug Manufacturers - General /530057

Vivanza Biosciences Ltd.

530057 (VIVANZA)

• BSE: 530057 • Delayed

1.98INR 0%

0.0210 USD

As of 20 June 2026, Vivanza Biosciences Ltd. has a market cap of $839.11K USD, ranking #48743 globally and #5129 in India. It ranks #4325 in the Healthcare sector, and #1360 in the Drug Manufacturers - General industry.

Global Rank

48743

Country Rank

5129

Sector Rank

4325

Industry Rank

1360

Key Stats

Market Cap

$839.11KUSD

79.2M INR

Enterprise Value

$1.85MUSD

174.51M INR

Revenue (TTM)

$11.67MUSD

1.1B INR

EBITDA (TTM)

$18.36KUSD

1.73M INR

Net Income (TTM)

-$16.2KUSD

-1.53M INR

EBITDA Margin

0.2%

Profit Margin

-0.1%

PS Ratio

0.1

PB Ratio

1.7

EV/EBITDA

100.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jayendra Mehta open_in_new

Employees

Founded

1982

Website

vivanzabiosciences.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	8.8%	10%	-4.8%	-1%	-10%	-14%	-88%	-78%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	530057 (VIVANZA) Vivanza Biosciences Ltd ISIN: INE984E01035 Shares Out.: Shares Outstanding: 40.0M¹ TV: TradingView: BSE: VIVANZA SA: Stock Analysis: BOM: 530057 YF: Yahoo Finance: 530057.BO GF: Google Finance: BOM: 530057 BA: Barron's: 530057 MS: Morningstar: XBOM: 530057	1.98 INR	TV: TradingView: BSE: VIVANZA SA: Stock Analysis: BOM: 530057 YF: Yahoo Finance: 530057.BO GF: Google Finance: BOM: 530057 BA: Barron's: 530057 MS: Morningstar: XBOM: 530057

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Vivanza Biosciences Ltd.

Vivanza Biosciences Limited engages in the research, development, manufacture, and distribution of pharmaceutical products in India. It offers latex surgical and examination, and latex free examination gloves, as well as other surgical products. The company was incorporated in 1982 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 5M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 2M%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 2M%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 1M%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 1M%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 1M%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 91M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 65M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 43M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 38M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 34M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 33M%	15.1	United States

chevron_leftBack